# Coty Inc.: financial statements, quarterly

COTY · NYSE · CIK 1024305 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/coty.md) · [Financials](/companies/coty/financials.md) · [Filings](/companies/coty/filings.md) · [Insiders](/companies/coty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/coty/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,641](/filings/0001024305-24-000071.md) | [1,728](/filings/0001024305-25-000007.md) | [1,386](/filings/0001024305-25-000018.md) | [1,363 d](/filings/0001024305-26-000048.md) | [1,672](/filings/0001024305-25-000065.md) | [1,670](/filings/0001024305-26-000014.md) | [1,299](/filings/0001024305-26-000029.md) | [1,252 d](/filings/0001024305-26-000048.md) | [1,577](/filings/0001024305-25-000065.md) | [1,679](/filings/0001024305-26-000014.md) | [1,282](/filings/0001024305-26-000029.md) | [1,269 d](/filings/0001024305-26-000048.md) |
| Cost of revenue | $m | [600](/filings/0001024305-24-000071.md) | [604](/filings/0001024305-25-000007.md) | [488](/filings/0001024305-25-000018.md) | [488 d](/filings/0001024305-26-000048.md) | [577](/filings/0001024305-25-000065.md) | [556](/filings/0001024305-26-000014.md) | [467](/filings/0001024305-26-000029.md) | [473 d](/filings/0001024305-26-000048.md) | [560](/filings/0001024305-25-000065.md) | [608](/filings/0001024305-26-000014.md) | [490](/filings/0001024305-26-000029.md) | [497 d](/filings/0001024305-26-000048.md) |
| Gross profit | $m | [1,042](/filings/0001024305-24-000071.md) | [1,124](/filings/0001024305-25-000007.md) | [898](/filings/0001024305-25-000018.md) | [875 d](/filings/0001024305-26-000048.md) | [1,095](/filings/0001024305-25-000065.md) | [1,114](/filings/0001024305-26-000014.md) | [832](/filings/0001024305-26-000029.md) | [780 d](/filings/0001024305-26-000048.md) | [1,017](/filings/0001024305-25-000065.md) | [1,071](/filings/0001024305-26-000014.md) | [792](/filings/0001024305-26-000029.md) | [773 d](/filings/0001024305-26-000048.md) |
| Selling, general and administrative | $m | [767](/filings/0001024305-24-000071.md) | [833](/filings/0001024305-25-000007.md) | [771](/filings/0001024305-25-000018.md) | [791 d](/filings/0001024305-26-000048.md) | [808](/filings/0001024305-25-000065.md) | [797](/filings/0001024305-26-000014.md) | [778](/filings/0001024305-26-000029.md) | [721 d](/filings/0001024305-26-000048.md) | [794](/filings/0001024305-25-000065.md) | [843](/filings/0001024305-26-000014.md) | [727](/filings/0001024305-26-000029.md) | [745 d](/filings/0001024305-26-000048.md) |
| Operating income | $m | [198](/filings/0001024305-24-000071.md) | [237](/filings/0001024305-25-000007.md) | [77.8](/filings/0001024305-25-000018.md) | [34.7 d](/filings/0001024305-26-000048.md) | [238](/filings/0001024305-25-000065.md) | [268](/filings/0001024305-26-000014.md) | [(280)](/filings/0001024305-26-000029.md) | [15.5 d](/filings/0001024305-26-000048.md) | [185](/filings/0001024305-25-000065.md) | [148](/filings/0001024305-26-000014.md) | [(372)](/filings/0001024305-26-000029.md) | [(42.7) d](/filings/0001024305-26-000048.md) |
| Interest expense | $m | [66.8](/filings/0001024305-23-000102.md) | [61.7](/filings/0001024305-24-000007.md) | [58.8](/filings/0001024305-24-000023.md) | [64.3 d](/filings/0001024305-26-000048.md) | [60.4](/filings/0001024305-25-000065.md) | [56.7](/filings/0001024305-26-000014.md) | [50.2](/filings/0001024305-26-000029.md) | [59.7 d](/filings/0001024305-26-000048.md) | [51.6](/filings/0001024305-25-000065.md) | [52.4](/filings/0001024305-26-000014.md) | [39.6](/filings/0001024305-26-000029.md) | [40.6 d](/filings/0001024305-26-000048.md) |
| Income tax | $m | [40.9](/filings/0001024305-24-000071.md) | [71.4](/filings/0001024305-25-000007.md) | [(5.4)](/filings/0001024305-25-000018.md) | [(11.8) d](/filings/0001024305-26-000048.md) | [42.0](/filings/0001024305-25-000065.md) | [26.0](/filings/0001024305-26-000014.md) | [(58.4)](/filings/0001024305-26-000029.md) | [(4.2) d](/filings/0001024305-26-000048.md) | [33.1](/filings/0001024305-25-000065.md) | [(52.4)](/filings/0001024305-26-000014.md) | [(53.2)](/filings/0001024305-26-000029.md) | [52.5 d](/filings/0001024305-26-000048.md) |
| Net income | $m | [1.6](/filings/0001024305-24-000071.md) | [181](/filings/0001024305-25-000007.md) | [3.8](/filings/0001024305-25-000018.md) | [(96.9) d](/filings/0001024305-26-000048.md) | [82.9](/filings/0001024305-25-000065.md) | [23.7](/filings/0001024305-26-000014.md) | [(406)](/filings/0001024305-26-000029.md) | [(68.8) d](/filings/0001024305-26-000048.md) | [67.9](/filings/0001024305-25-000065.md) | [(124)](/filings/0001024305-26-000014.md) | [(408)](/filings/0001024305-26-000029.md) | [(141) d](/filings/0001024305-26-000048.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001024305-24-000071.md) | [0.20](/filings/0001024305-25-000007.md) | [0.00](/filings/0001024305-25-000018.md) | not reported | [0.09](/filings/0001024305-25-000065.md) | [0.02](/filings/0001024305-26-000014.md) | [(0.47)](/filings/0001024305-26-000029.md) | not reported | [0.07](/filings/0001024305-25-000065.md) | [(0.14)](/filings/0001024305-26-000014.md) | [(0.47)](/filings/0001024305-26-000029.md) | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001024305-24-000071.md) | [0.20](/filings/0001024305-25-000007.md) | [0.00](/filings/0001024305-25-000018.md) | not reported | [0.09](/filings/0001024305-25-000065.md) | [0.02](/filings/0001024305-26-000014.md) | [(0.47)](/filings/0001024305-26-000029.md) | not reported | [0.07](/filings/0001024305-25-000065.md) | [(0.14)](/filings/0001024305-26-000014.md) | [(0.47)](/filings/0001024305-26-000029.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001024305-23-000102.md) | [0.5](/filings/0001024305-24-000007.md) | [0.3](/filings/0001024305-24-000023.md) | [0.3](/filings/0001024305-25-000030.md) | [0.3](/filings/0001024305-24-000071.md) | [0.2](/filings/0001024305-25-000007.md) | [0.2](/filings/0001024305-25-000018.md) | [0.3](/filings/0001024305-26-000048.md) | [0.3](/filings/0001024305-25-000065.md) | [0.4](/filings/0001024305-26-000014.md) | [0.3](/filings/0001024305-26-000029.md) | [0.2](/filings/0001024305-26-000048.md) |
| Current assets | $bn | [2.2](/filings/0001024305-23-000102.md) | [2.4](/filings/0001024305-24-000007.md) | [2.0](/filings/0001024305-24-000023.md) | [2.0](/filings/0001024305-25-000030.md) | [2.2](/filings/0001024305-24-000071.md) | [2.0](/filings/0001024305-25-000007.md) | [1.9](/filings/0001024305-25-000018.md) | [2.0](/filings/0001024305-26-000048.md) | [2.2](/filings/0001024305-25-000065.md) | [2.2](/filings/0001024305-26-000014.md) | [1.9](/filings/0001024305-26-000029.md) | [1.9](/filings/0001024305-26-000048.md) |
| Total assets | $bn | [12.6](/filings/0001024305-23-000102.md) | [13.0](/filings/0001024305-24-000007.md) | [12.3](/filings/0001024305-24-000023.md) | [12.1](/filings/0001024305-25-000030.md) | [12.5](/filings/0001024305-24-000071.md) | [11.7](/filings/0001024305-25-000007.md) | [11.5](/filings/0001024305-25-000018.md) | [11.9](/filings/0001024305-26-000048.md) | [12.1](/filings/0001024305-25-000065.md) | [11.1](/filings/0001024305-26-000014.md) | [10.2](/filings/0001024305-26-000029.md) | [10.2](/filings/0001024305-26-000048.md) |
| Current liabilities | $bn | [2.8](/filings/0001024305-23-000102.md) | [2.9](/filings/0001024305-24-000007.md) | [2.5](/filings/0001024305-24-000023.md) | [2.6](/filings/0001024305-25-000030.md) | [2.6](/filings/0001024305-24-000071.md) | [2.7](/filings/0001024305-25-000007.md) | [2.4](/filings/0001024305-25-000018.md) | [2.5](/filings/0001024305-26-000048.md) | [2.5](/filings/0001024305-25-000065.md) | [2.8](/filings/0001024305-26-000014.md) | [2.4](/filings/0001024305-26-000029.md) | [2.5](/filings/0001024305-26-000048.md) |
| Total liabilities | $bn | [8.5](/filings/0001024305-23-000102.md) | [8.2](/filings/0001024305-24-000007.md) | [7.9](/filings/0001024305-24-000023.md) | [7.8](/filings/0001024305-25-000030.md) | [8.0](/filings/0001024305-24-000071.md) | [7.5](/filings/0001024305-25-000007.md) | [7.6](/filings/0001024305-25-000018.md) | [8.0](/filings/0001024305-26-000048.md) | [8.0](/filings/0001024305-25-000065.md) | [7.1](/filings/0001024305-26-000014.md) | [6.7](/filings/0001024305-26-000029.md) | [6.8](/filings/0001024305-26-000048.md) |
| Long-term debt | $bn | [4.1](/filings/0001024305-23-000102.md) | [3.7](/filings/0001024305-24-000007.md) | [3.9](/filings/0001024305-24-000023.md) | [3.8](/filings/0001024305-25-000030.md) | [3.9](/filings/0001024305-24-000071.md) | [3.4](/filings/0001024305-25-000007.md) | [3.8](/filings/0001024305-25-000018.md) | [4.0](/filings/0001024305-26-000048.md) | [4.0](/filings/0001024305-25-000065.md) | [3.0](/filings/0001024305-26-000014.md) | [3.2](/filings/0001024305-26-000029.md) | [3.0](/filings/0001024305-26-000048.md) |
| Current portion of debt | $bn | [0.0](/filings/0001024305-23-000102.md) | [0.0](/filings/0001024305-24-000007.md) | [0.0](/filings/0001024305-24-000023.md) | [0.0](/filings/0001024305-25-000030.md) | [0.0](/filings/0001024305-24-000071.md) | [0.0](/filings/0001024305-25-000007.md) | [0.0](/filings/0001024305-25-000018.md) | [0.0](/filings/0001024305-26-000048.md) | [0.0](/filings/0001024305-25-000065.md) | [0.0](/filings/0001024305-26-000014.md) | [0.0](/filings/0001024305-26-000029.md) | [0.0](/filings/0001024305-26-000048.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001024305-23-000102.md) | [0.0](/filings/0001024305-24-000007.md) | [0.0](/filings/0001024305-24-000023.md) | [0.0](/filings/0001024305-25-000030.md) | [0.0](/filings/0001024305-24-000071.md) | [0.0](/filings/0001024305-25-000007.md) | [0.0](/filings/0001024305-25-000018.md) | [0.0](/filings/0001024305-26-000048.md) | [0.0](/filings/0001024305-25-000065.md) | [0.0](/filings/0001024305-26-000014.md) | [0.0](/filings/0001024305-26-000029.md) | [0.0](/filings/0001024305-26-000048.md) |
| Shareholders' equity | $bn | [3.7](/filings/0001024305-23-000102.md) | [4.4](/filings/0001024305-24-000007.md) | [4.0](/filings/0001024305-24-000023.md) | [3.8](/filings/0001024305-25-000030.md) | [4.0](/filings/0001024305-24-000071.md) | [3.8](/filings/0001024305-25-000007.md) | [3.5](/filings/0001024305-25-000018.md) | [3.5](/filings/0001024305-26-000048.md) | [3.6](/filings/0001024305-25-000065.md) | [3.5](/filings/0001024305-26-000014.md) | [3.1](/filings/0001024305-26-000029.md) | [3.0](/filings/0001024305-26-000048.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [186](/filings/0001024305-24-000071.md) | [422 d](/filings/0001024305-25-000007.md) | [(170) d](/filings/0001024305-25-000018.md) | [177 d](/filings/0001024305-26-000048.md) | [67.4](/filings/0001024305-25-000065.md) | [465 d](/filings/0001024305-26-000014.md) | [(123) d](/filings/0001024305-26-000029.md) | [83.2 d](/filings/0001024305-26-000048.md) | [65.2](/filings/0001024305-25-000065.md) | [560 d](/filings/0001024305-26-000014.md) | [(203) d](/filings/0001024305-26-000029.md) | [116 d](/filings/0001024305-26-000048.md) |
| Capital expenditure | $m | [62.2](/filings/0001024305-24-000071.md) | [58.9 d](/filings/0001024305-25-000007.md) | [64.3 d](/filings/0001024305-25-000018.md) | [59.8 d](/filings/0001024305-26-000048.md) | [75.3](/filings/0001024305-25-000065.md) | [45.5 d](/filings/0001024305-26-000014.md) | [45.9 d](/filings/0001024305-26-000029.md) | [48.3 d](/filings/0001024305-26-000048.md) | [54.0](/filings/0001024305-25-000065.md) | [46.6 d](/filings/0001024305-26-000014.md) | [45.6 d](/filings/0001024305-26-000029.md) | [43.4 d](/filings/0001024305-26-000048.md) |
| Dividends paid | $m | [3.3](/filings/0001024305-24-000071.md) | [3.5 d](/filings/0001024305-25-000007.md) | not reported | not reported | [3.3](/filings/0001024305-24-000071.md) | [3.4 d](/filings/0001024305-26-000014.md) | [3.2 d](/filings/0001024305-26-000029.md) | not reported | not reported | not reported | [3.3 d](/filings/0001024305-26-000029.md) | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [882](/filings/0001024305-23-000102.md) | [887](/filings/0001024305-24-000007.md) | [865](/filings/0001024305-24-000023.md) | [854](/filings/0001024305-24-000071.md) | [923](/filings/0001024305-25-000007.md) | [892](/filings/0001024305-25-000018.md) | [875](/filings/0001024305-25-000065.md) | [875](/filings/0001024305-26-000014.md) | [872](/filings/0001024305-26-000029.md) | [876](/filings/0001024305-25-000065.md) | [877](/filings/0001024305-26-000014.md) | [880](/filings/0001024305-26-000029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 880,686,464 at 2026-08-12, from the cover of the [10-K filed 2026-08-20](/filings/0001024305-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.
